Hot Topic at Schwartz Rounds: Stress


Attend the upcoming Schwartz Center Rounds, “Providing Compassionate Care in Times of Stress,” Friday, April 13, noon to 1 pm (lunch 11:45 am). Place the forum in your schedule by downloading the outlook calendar appointment. Located in the Faculty Conference Room, S1-342, University Campus, this event is an opportunity to discuss the role stress plays in providing compassionate care. Featured panelists include Thomas Guggina, MD, Boris Lorberg, MD, Christine Runyan, PhD, and Jennifer LaFemina, MD. One contact hour will be provided for nurses and physicians, and preregistration is not required. Email with questions, ideas for topics or to join the rounds planning committee. Learn more.

Q&A with Dr. LaFemina: Learn about Her Calling to Cancer Care

Dr. LaFemina (Worcester Business Journal photo)

Surgical oncologist Jennifer LaFemina, MD, was recently profiled in Central Mass Health, the quarterly health care magazine published by Worcester Business Journal. She said, “The breast cancer population is very special, I find. It’s generally a very educated population who is scared and anxious, yet proactive and I just find particular satisfaction in that group.” Read the article and learn what inspired Dr. LaFemina to become a physician and work with breast cancer patients, as well her current research work with Alliance Trial. Visit our Facebook page to share you feedback and read comments shared by her patients and colleagues.

Pancreas Program Leaders Launch Innovative Study 

PancreaticOur Medical Center is in the beginning stages of launching a prospective pilot study to evaluate the role aspirin has on reducing the risk of pancreatic cancer in high-risk patients. “Anti-inflammatories have proven to be effective in reducing the risk of colorectal cancer,” explained Jennifer LaFemina, MD, surgical oncology. “Physicians were able to find that when anti-inflammatories were taken by patients, they had a decreased risk of precancerous polyps in both the sporadic (random) and high-risk settings. We want to see if the same applies to pancreatic cancer.” Read more.